x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Psychopharmacology and Psychiatry Updates

Psychopharmacology Institute

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

health & fitness medicine

All Episodes

09:24

Lamotrigine and Lithium Combination Therapy for Rapid...

Psychopharmacology and Psychiatry Updates ·

2023/05/17

In this episode, we discuss rapid cycling bipolar disorder and its treatment, focusing on the use of the combination of lamotrigine and lithium. We also highlight the importance of checking thyroid status and tapering antidepressants in patients with rapid cycling. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 45 Lamotrigine and Lithium Combination for Treatment of Rapid Cycling Bipolar Disorder: Results From

en

12:17

Melatonin and Secretin for Youth

Psychopharmacology and Psychiatry Updates ·

2023/05/12

In this episode, we discuss the potential use of melatonin as a safe and effective pharmacotherapy for sleep disturbances in children with ADHD and ASD. Did you know that up to 80% of children with ASD experience sleep disorders? Listen in to learn how melatonin can help improve sleep onset and duration in these patients. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Atypical Psychopharmacologic Strategies for Children and

en

08:17

Tackling NSSI in Adolescents: Can Medications Help?

Psychopharmacology and Psychiatry Updates ·

2023/05/07

Which medications are safe and effective for treating nonsuicidal self-injury (NSSI) in children and adolescents? In this episode, we discuss the use of psychotropic medications in treating NSSI, which is becoming increasingly common in this population and can predict future suicide attempts. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 05 Psychotropic Drugs for Treating Nonsuicidal Self‑Injury in the Youth

en

14:08

D-Cycloserine for Anxiety Disorders in Youth

Psychopharmacology and Psychiatry Updates ·

2023/05/02

This episode discusses D-cycloserine’s potential indications and administration in children and adolescents, including the evidence for anxiety disorders, OCD, ASD, and PTSD. It also mentions the dosage, administration, benefits, and side effects of D-cycloserine in youth. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Atypical Psychopharmacologic Strategies for Children and Adolescents D-Cycloserine: Potential Indications and

en

07:51

Clinical Significance of Antidepressants for the...

Psychopharmacology and Psychiatry Updates ·

2023/04/27

Antidepressants are commonly used to treat depression, but how effective are they? In this episode, we discuss the concept of the minimal clinically important difference (MCID) and how it can be applied to assess antidepressant efficacy in treating depression. Specifically, knowing MCID estimates helps to shed light on recent controversies regarding antidepressant efficacy. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 44

en

12:30

Memantine: Potential Indications in Youth

Psychopharmacology and Psychiatry Updates ·

2023/04/22

What is the role of memantine in pediatric populations? This episode discusses memantine’s potential indications and administration in children and adolescents, an explanation of the theory of glutamatergic dysregulation, and the evidence of memantine for ASD, OCD, and mood disorders. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Atypical Psychopharmacologic Strategies for Children and Adolescents Memantine: Potential Indications in

en

09:50

Low-Dose Olanzapine for Anorexia Nervosa

Psychopharmacology and Psychiatry Updates ·

2023/04/17

In this episode, we examine the tolerability, safety, and effectiveness of low-dose olanzapine in adolescents with anorexia nervosa (AN). Learn about the potential benefits and risks of using olanzapine in AN patients and the importance of a multidisciplinary approach in treating this challenging population. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 05 Low-Dose Olanzapine for Treating Adolescents With Anorexia

en

13:13

Naltrexone in Youth: Exploring Potential Applications...

Psychopharmacology and Psychiatry Updates ·

2023/04/12

In this episode, we discuss the potential uses and challenges of naltrexone in children and adolescents while addressing the limited and conflicting evidence. We also examine the dosage, side effects, and important considerations for using naltrexone in young populations. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Atypical Psychopharmacologic Strategies for Children and Adolescents Naltrexone: Potential Indications and

en

10:26

Lamotrigine Titration: Slowing Down for Safer Treatment

Psychopharmacology and Psychiatry Updates ·

2023/04/07

Would a slower lamotrigine titration rate decrease the likelihood of developing the dreaded lamotrigine-associated rash? This episode discusses the possible advantages of slower lamotrigine titration rates, tips for managing benign rashes, and when to rechallenge lamotrigine. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 44 Impact of Selected Initial Titration Schedules on Safety and Long-Term Effectiveness of Lamotrigine

en

06:49

Using Benzodiazepines in Geriatric Patients

Psychopharmacology and Psychiatry Updates ·

2023/04/02

In this episode, we dive into a topic that's especially relevant for those working with older adults: The use of benzodiazepines and sedative-hypnotics. We explore the unique considerations of prescribing these medications to geriatric patients and the importance of deprescribing them when possible. Faculty: Lauren Gerlach, D.O. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Updates on Geriatric Psychopharmacology Considerations for Using Benzodiazepines and

en

12:23

Lithium Use in Pediatric Patients

Psychopharmacology and Psychiatry Updates ·

2023/03/28

In this episode, we delve into lithium's efficacy and potential long-term effects in younger patients and what clinicians should carefully monitor in this population. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 04 Long-Term Effects of Lithium Use on Children and Adolescents

en

08:14

Using Mood Stabilizers in the Geriatric Population

Psychopharmacology and Psychiatry Updates ·

2023/03/23

Are mood stabilizers the right choice for elderly patients? This episode discusses key insights about using mood stabilizers in the geriatric population, including side effects and monitoring for lithium, valproic acid, lamotrigine, carbamazepine, and gabapentinoids. Faculty: Lauren Gerlach, D.O. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Updates on Geriatric Psychopharmacology Considerations for Using Mood Stabilizers in the Geriatric Population

en

08:22

Bright Light Therapy for Perinatal Depression

Psychopharmacology and Psychiatry Updates ·

2023/03/18

Do you have a patient suffering from postpartum depression? In this episode, we discuss a new study on light therapy as a potential treatment for postpartum depression, including the response rate, adverse effects, and effects on sleep quality. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 43 Efficacy of Bright Light Therapy in Perinatal Depression: A Randomized, Double-Blind, Placebo-Controlled Study

en

18:08

Using SSRIs in the Geriatric Population

Psychopharmacology and Psychiatry Updates ·

2023/03/13

This episode discusses some strategies for starting antidepressants in the elderly, the important role of titrating doses, the efficacy of SSRIs, the side effects and drug–drug interactions of different medications, and clinical tips for using SSRIs and SNRIs in this population. Faculty: Lauren Gerlach, D.O. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Updates on Geriatric Psychopharmacology Using SSRIs and SNRIs in the Geriatric Population

en

08:24

Safety and Efficacy of Duloxetine in Youth With MDD

Psychopharmacology and Psychiatry Updates ·

2023/03/08

Is duloxetine a viable option for youth with MDD? In this episode, we discuss the need for additional medication options in youth with depression as well as an RCT of duloxetine to assess its efficacy and a label extension trial to evaluate its long-term safety. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 04 Efficacy and Safety of Duloxetine in Children and Adolescents With MDD in Japan

en

07:30

Challenges in Prescribing Psychotropics to the...

Psychopharmacology and Psychiatry Updates ·

2023/03/03

What are the most common challenges when prescribing psychotropics to older adults? This episode discusses the challenges in prescribing psychotropics to the geriatric population, such as poor medication adherence and the risks of inappropriate prescribing. It also introduces a clinical case and emphasizes the importance of medication reconciliation. Faculty: Lauren Gerlach, D.O. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Updates on Geriatric Psychopharmacology

en

07:41

Antidepressants and Vertebral and Hip Risk Fractures

Psychopharmacology and Psychiatry Updates ·

2023/02/26

In this episode, we discuss an updated review of 11 studies that seek to evaluate the effect of antidepressants on the risk of hip and vertebral bone fractures. Although the overall effect size seems large, the absolute risk increase might be small. Faculty: Jim Phelps, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 43 Antidepressants and Vertebral and Hip Risk Fracture: An Updated Systematic Review and Meta-Analysis

en

06:55

Antidepressants and Mood Stabilizers for Managing...

Psychopharmacology and Psychiatry Updates ·

2023/02/21

Are antidepressants effective for managing explosive behavior? In this episode, we discuss the efficacy of antidepressants and mood stabilizers for managing explosive behavior, including some proposed doses of lithium and divalproex sodium, and the indications for using antidepressants. Faculty: Carrie Vaudreuil, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Managing Explosive Behavior in Children and Adolescents Antidepressants and Mood Stabilizers for

en

11:21

Risk of Substance Use Disorders in Children Treated...

Psychopharmacology and Psychiatry Updates ·

2023/02/16

In this episode, we discuss a meta-analysis that included 6 million patients to assess whether pharmacotherapy increases the risk of substance use or misuse, specifically the risk of using stimulant medications in children with ADHD. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Smart Takes Vol. 03 Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders

en

08:55

FGAs and SGAs for Managing Explosive Behavior

Psychopharmacology and Psychiatry Updates ·

2023/02/11

In this episode, we discuss the SGAs with the most evidence for explosive behavior, their side effects, and monitoring recommendations. We also address the reasons for considering other SGAs and clarify which FGA has the most evidence for aggression. Faculty: Carrie Vaudreuil, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Managing Explosive Behavior in Children and Adolescents First- and Second-Generation Antipsychotics for Managing Explosive Behavior

en

431 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown